Adult Allo-SCT Survivor Clinical Trial
Official title:
Developing and Assessing the Feasibility of Implementing a Video Web-based Patient Education Application
| NCT number | NCT02812082 |
| Other study ID # | 16-769 |
| Secondary ID | |
| Status | Withdrawn |
| Phase | N/A |
| First received | June 20, 2016 |
| Last updated | September 13, 2016 |
| Start date | June 2016 |
The purpose of this study is to develop an interactive web-based patient education program to help educate patients about the increased risk of MS and its cardiac risk factors following allo-SCT and to inform and motivate patients how to make lifestyle changes. This program will be used in addition to counseling at participants clinic visits. The investigators are not changing the recommendations for prevention and management of these conditions, but rather are trying to improve the way they provide this education to patients.
| Status | Withdrawn |
| Enrollment | 0 |
| Est. completion date | |
| Est. primary completion date | June 2017 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 21 Years and older |
| Eligibility |
Inclusion Criteria: - The option to participate will be offered to male and female allo-SCT patients at MSK = 21 years of age who are greater than 90 days post-transplant and followed in or referred to the adult allo-SCT survivorship clinic at MSK - The option to participate will be offered to male and female allo-SCT patients at MSK = 21 years of age who are greater than 90 days post-transplant and disease free, but have not yet been referred to the survivorship clinic - Able to understand written and oral English Exclusion Criteria: - Patients less than 90 days post-transplant - Patients without internet access - Adult post-transplant patients who have relapsed prior to study recruitment |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| United States | Memorial Sloan Kettering Cancer Center | New York | New York |
| Lead Sponsor | Collaborator |
|---|---|
| Memorial Sloan Kettering Cancer Center |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Percentage of patients that use the application | A successful trial will be when = 50% of enrolled patients use the application. | 1 year | No |